MT
Majesty Therapeutics, Inc.
SEC filingBiotechnology · Sea Ranch Lakes, FL
Amount raised$100Ksold at filing
Total offering$5M$4.9M still open
Investors in the raise3count reported to the SEC
FiledMay 15, 2026first sale May 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Shawn TitcombExecutive Officer, Director
Adrian HepnerExecutive Officer
Ankit BhargavaExecutive Officer
Executive officers, directors and promoters as listed on the Form D.